Hudock Inc’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Hudock Inc’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-224	Closed	-$48K	–	889
2021 Q1	$48K	Hold	224	–	–	0.02%	317
2020 Q4	$25K	Hold	224	–	–	0.01%	392
2020 Q3	$21K	Hold	224	–	–	0.01%	374
2020 Q2	$27K	Hold	224	–	–	0.01%	336
2020 Q1	$19K	Hold	224	–	–	0.01%	334
2019 Q4	$23K	Buy	224 +50	+29%	+$5.61K	0.01%	330
2019 Q3	$20K	Buy	174 +104	+149%	+$15.8K	0.01%	353
2019 Q2	$12K	Hold	70	–	–	﹤0.01%	406
2019 Q1	$11K	Buy	+70	New	+$10.4K	﹤0.01%	405
2014 Q4	–	Sell	-150	Closed	-$12K	–	604
2014 Q3	$12K	Buy	150 +30	+25%	+$2.65K	0.01%	378
2014 Q2	$13K	Buy	+120	New	+$8.35K	0.01%	378

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Hudock Inc's GWPH Position: Q2 2021 in Review

Hudock Inc sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 224 shares — an estimated $48K sold.

Hudock Inc first reported a position in GWPH in Q2 2014 and held it in 11 quarters. The position peaked at $48K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Hudock Inc reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Hudock Inc sold 224 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $48K.
Hudock Inc first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 11 quarters.
Hudock Inc's GW Pharmaceuticals Plc American Depositary Shares position peaked at $48K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Hudock Inc's 13F filing for Q2 2021, filed 9 Aug 2021.